EDUCATION AND TRAINING
M.D., University of Washington
Residency, University of California at Davis, Family Practice and Internal Medicine
Fellowship, University of Washington, Division of Nephrology
|
|
Susan Ott, M.D.
Associate Professor of Medicine
Division of Metabolism, Endocrinology and Nutrition
OFFICE ADDRESS
University of Washington Medical Center
1959 NE Pacific
UW Mailbox 356426
Seattle, WA 98195-6426
CURRENT RESEARCH INTERESTS
Clinical and bone histomorphometric studies of bone metabolism.
Effects of contraception and lifestyle on bone density in adolescents;
mineralization density of bone; bone histomorphometry of women with
breast cancer; renal osteodystrophy.
REPRESENTATIVE PUBLICATIONS
Ott SM, Chesnut CH: Calcitriol treatment is not effective in postmenopausal osteoporosis.
Ann Intern Med 110:267-274, 1989.
Ott SM, Lipkin EW, Newell-Morris L: Bone physiology during
pregnancy and lactation in young macaques. J Bone Mineral Res
14:1779-1788, 1999.
Ott SM, Oleksik A, Lu Y, Harper K, Lips P: Bone
histomorphometric and biochemical marker results of a two-year placebo
controlled trial of Raloxifene in postmenopausal women. J Bone
Mineral Res 17:341-348, 2002.
Scholes D, LaCroix AZ, Ichikawa LE, Barlow WE, Ott SM:
Injectable hormone contraception and bone density: Results from
a prospective study. Epidemiology 13:581-587, 2002.
Ott SM: Long-term safety of bisphosphonates. J Clin
Endocrinol Metab 90:1897-1899, 2005.
Ott SM: Sclerostin and Wnt signaling--the pathway to bone
strength. J Clin Endocrinol Metab 90:6741-6743, 2005.
Moe S, Drueke T, Cunningham J, Goodman W, Martin K, Olgaard K, Ott S,
Sprague S, Lameire N, Eknoyan G, Kidney Disease: Improving Global
Outcomes (KDIGO): Definition, evaluation, and classification of
renal osteodystrophy: a position statement from Kidney Disease:
Improving Global Outcomes (KDIGO). Kidney Int 69:1945-1953,
2006.
Visit Dr. Ott's osteoporosis web site at http://courses.washington.edu/bonephys
|
